CME/CE Accredited Session
Sponsored by Industry
Click For Session Details
Session Times Listed in ET
Jacob Levitt, MD, FAAD | Yvonne I. Chu, MD, MBA
What do primary care providers need to know about rashes and eye complaints in the acute care setting? Join expert faculty as they review important questions they get asked about these topics!
Professor and Vice Chairman, Department of Dermatology, Mount Sinai Medical Centerr, New York, NY
Associate Professor, Department of Ophthalmology, Cullen Eye Institute, Baylor College of Medicine, Houston, TX
Kenneth A. Alexander, MD, PhD | Anna R. Giuliano, PhD
The epidemiology of human papillomavirus (HPV)-related cancers is changing. New cases of HPV-related oropharyngeal cancer in men now outnumber cases of cervical cancer in women. Prevention of HPV-related cancers is a public health priority. In this session, expert faculty will discuss how HPV-related disease can be prevented and even eliminated.
Professor of Clinical Sciences, University of Central Florida College of Medicine, Chief, Division of Infectious Diseases, Nemours Children’s Hospital, Orlando, Florida
Clinical Research Professor, Dorothea Bennett Memorial, American Cancer SocietyDirector, Center for Immunization and Infection Research in Cancer, Moffitt Cancer Center, Tampa, Florida
Supported by Merck & Co. Inc.
A Proactive Way to Treat IBS-D: Post-Marketing Information and Phase 4 Data
Darren M. Brenner, MD
Please join us in a clinical review of exciting Phase 4 data and the latest post-marketing information on a proactive treatment that may help your IBS-D patients. IBS-D is a chronic functional disorder of the GI system that affects approximately 16 million people.
Associate Professor of Medicine and Surgery in the Division of Gastroenterology at Northwestern University
Sponsored by AbbVie
The Continuum of Heart Failure
Kris Vijay, MD, MS, FACP, FACC, FNLA, FCRS, FHFSA
The objective of this program is to discuss the pathophysiology, disease burden, and management of heart failure (HF). The program will present data on HF prevalence and health outcomes, review the implications of type 2 diabetes as a common comorbidity, and provide guidance on diagnosing HF. It will conclude with a brief overview of current treatment options for HF.
Medical Director, CHF, Abrazo Arizona Heart Hospital and Abrazo Health Network Clinical Professor of Medicine, University of Arizona, Founding Member and Past President, Cardiorenal Society of America (CRSA)
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC
This session will contain a number of clinical cases you are likely to see in a primary care setting. Dr. Marcelli will discuss how to correctly interpret the clinical presentation and thyroid function tests, leading to an accurate diagnosis and appropriate treatment.
Marco Marcelli, MD, Professor of Medicine, Acting Chief, Division of Endocrinology, Baylor College of Medicine, Chief Endocrine Services, Michael DeBakey VA Medical Center, Houston, TX
Katherine E. Galluzzi, DO, CMD, FACOFP
In this session, the speaker will discuss some challenging cases that primary care practitioners may face in their practice. These cases will range from sexual dysfunction treatment in women, Options for dealing with “difficult” patients, and recognizing burnout in clinical settings.
Professor and Chair, Department of Geriatrics, Philadelphia College of Osteopathic Medicine, Philadelphia, PA
Applying Guidelines and Real-World Evidence to COPD Management
Stephen A. Brunton, MD, FAAFP
Early and accurate diagnosis of chronic obstructive pulmonary disease (COPD) followed by optimal management are very important. This educational activity will discuss the diagnosis of COPD, goals for treatment, pharmacological management, and the role of inhaled therapy and inhaler choice in the management of patients with COPD.
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.
Ted Okerson, MD, FACP, FACE
Describe the Progressive nature of CKD leading to significant morbidity and mortality.
Discuss the disease burden of CKD and importance of screening and diagnosis.
SGTL2i as recommended part of initial therapy in patients with T2D and CKD.
Overview of DAPA-CKD trial and trial endpoints.
Sponsored by AstraZeneca
Rachel M. Bond, MD, FACC | Ty J. Gluckman, MD, FACC, FAHA
Join Dr. Ty Gluckman and Dr. Rachel Bond as they discuss important areas in cardiology where primary care clinicians can make a big difference. These topics include recognizing aortic and thoracic aneurisms, including screening in appropriate populations. Also included are updates in lipids management.
System Director, Women's Heart Health, Dignity Health, Arizona, Assistant Professor, Department of Internal Medicine, Creighton University School of Medicine
Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS), Providence Heart Institute, Providence St. Joseph Health, Portland, OR
Ted Okerson, MD, FACP, FACE
Sponsored by AstraZeneca Pharmaceuticals, LP
Christopher Chiodo, MD | Aashish Didwania, MD
What do primary care providers need to know about acute care ankle pain and dizziness? Join expert faculty as they review important questions they get asked about these topics!
Foot and Ankle Division Chief, Brigham and Women's Hospital, Boston, MA
IM Residency Director, Associate Vice Chair of Education,, Northwestern University Feinberg School of Medicine, Chicago, IL
Top 10 Guideline Recommendations About Irritable Bowel Syndrome and Chronic Idiopathic Constipation
Philip Schoenfeld, MD, MSEd, MSc
Primary care providers frequently see patients complaining of abdominal bloating, cramping, or discomfort associated with diarrhea or constipation. Evidence-based guidelines are available, but recommendations developed using the GRADE framework may appear vague. Experts will discuss interpretation and implementation of recommendations developed through the GRADE framework. Recent American College of Gastroenterology Management of Irritable Bowel Syndrome guidelines recommend multiple new diets, treatments, and diagnostic tools to optimize treatment. Finally, appropriate evaluation of these patients includes a careful digital rectal exam. A variety of ano-rectal findings, including anal fissures, hemorrhoids, warts, etc. will be shown as well as identifying pelvic floor dysfunction on rectal exam.
Chief (Emeritus) - Gastroenterology Section, John D. Dingell VA Medical Center, Detroit, MI
Supported by AbbVie Inc. & Salix Pharmaceuticals, Inc.
Path To Diagnosis, Mapping Symptoms of Inflammatory Back Pain
Samy Metyas, M.D, MSc, FACR, FACP
Sponsored by AbbVie
After Metformin: What Are Your Options?
Javier Morales, MD, FACP, FACE
Explore the roles of native GLP-1 in T2D pathophysiology. Review the recommendations from national association guidelines on the treatment options after metformin in the T2D treatment algorithm. Evaluate the efficacy and safety results from a monotherapy trial of a once-daily GLP-1 RA as well as 2 other head-to-head clinical trials, including vs an SGLT-2i and a DPP-4i. Evaluate the safety data from a cardiovascular outcomes trial, followed by dosing and administration information.
Vice President, Principal Trials Investigator, Advanced Internal Medicine Group, PC, Greenvale, New York
Sponsored by Novo Nordisk Inc.
Jeffrey Rado, MD, MPH, FAPA
Bipolar disorder is common, affecting approximately 1% of the population. Individuals most often initially seek help in primary care settings, but diagnosis can be challenging even for seasoned clinicians. This presentation will review common and uncommon presentations of bipolar, including tips to making the diagnosis. Initial treatment strategies will also be discussed.
Associate Professor, Northwestern Feinberg School of Medicine, Chicago, IL
Charles Vega, MD, FAAFP
Stay up to date with the latest USPSTF recommendations for screening and preventive interventions in primary care. Walk away from this session with a firm grasp of the evidence of benefits vs harms for each of these recommendations so that you and your patients are positioned to make the best decisions for their care.
Health Sciences Clinical Professor, UC Irvine Department of Family Medicine, Assistant Dean for Culture and Community Education, UC Irvine School of Medicine Director, UC Irvine Program in Medical Education for the Latino Community, Irvine, CA
Unmet Need of Cancer Screening and the Potential of Multi-Cancer Early Detection Tests
Whitney Jones, MD | Mylynda B. Massart, MD, PhD | Candace Westgate, MD
The “war on cancer” began 50 years ago, but despite significant advancements in therapeutics, the oncology community has not yet been able to declare victory. While important progress has been made in essential, life-saving single-cancer screenings, early detection technology still only exists for a few cancers. Multi-cancer early detection technology has the ability to screen for over 50 types of cancer. We will explore current cancer screening methods and how these new technologies may improve cancer mortality rates.
Senior Medical Director, Medical Affiars, GRAIL
Sponsored by GRAIL, LLC
Dareen Siri, MD, FAAAAI, FACAAI | Neil Skolnik, MD
EDDUCATE is a medical education program designed to highlight the unmet need for eosinophil (EOS) testing in the diagnosis and management of EOS-driven diseases. EDDUCATE is intended to (1) increase awareness and understanding of the importance of blood EOS testing on improving diagnosis and phenotyping in severe eosinophilic asthma (SEA); (2) Educate on the role of the EOS as a biomarker in SEA & the prognostic value of EOS biomarkers in SEA; and (3) Understand the risks of oral corticosteroids in the management of patients with SEA, and the importance of referral to a specialist for additional management consideration.
Midwest Allergy Sinus Asthma SC, CEO/CMO, SWIA Clinical Research LLC, Medical Director
Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University Associate Director, Family Medicine Residency Program, Abington Jefferson Health
Sponsored by GlaxoSmithKline
Stephanie Faubion, MD, MBA, FACP, NCMP, IF
Understand the implications of recent practice-changing studies in women’s health in this 60-minute course covering important topics such as genetic testing for high-risk mutations for breast cancer, osteoporosis and cervical cancer screening, and symptoms associated with the menopause transition.
Professor and Chair, Department of Medicine, Mayo Clinic Florida, Director, Mayo Clinic Women's Health, Medical Director, The North American Menopause Society
Paul E. Sax, MD | Jacob H. Johnson, MD
This pandemic requires communication among specialists and primary care clinicians. In this COVID-19 panel, expert faculty will team up to discuss the most pressing and frequently asked questions about the disease and its complications.
Clinical Director, Division of Infectious Diseases, Brigham and Women's Hospital, Professor of Medicine, Harvard Medical School, Boston, MA
Associate Physician, Division of Infectious Disease, Brigham and Women's Hospital, Boston, MA
Understanding Chronic Cough: Patient Presentation and Assessment
Mandel Sher, MD
Sponsored by Merck
Polyvascular Patients: Are You Doing Enough to Reduce Risk of Recurrent Events?
Christian T. Ruff, MD, MPH | Elaine Hylek, MD, MPH
Cardiology expert, Christian Ruff, MD, MPH & primary care specialist, Elaine Hylek, MD, MPH will review the latest research and recommendations for patients with polyvascular disease. The faculty also will discuss patient cases that cover long-term atherothrombotic risks, chronic coronary artery disease (CAD)/peripheral artery disease (PAD), benefits of direct oral anticoagulants (DOACs), and considerations for the multidisciplinary team.
Assistant Professor of Medicine, Harvard Medical School, Investigator, TIMI Study Group, Cardiovascular Division, Brigham and Women’s Hospital, Boston, MA
Professor of Medicine, Boston University School of Medicine, Director, Thrombosis and Anticoagulation Service, Boston Medical Center, Boston, MA
Supported by Janssen Scientific Affairs, LLC